Overall, TUBA1C exhibits a common function across various cancer types, regulating the PI3K/AKT and cell cycle-related pathways and reshaping the TME, thereby influencing tumor progression and, consequently, leading to poor clinical outcomes. This evidence concerns the gene TUBA1C and cancer.